0 (0%) | 06-28 18:07 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 15.54 | 1-year : | 18.15 |
Resists | First : | 13.31 | Second : | 15.54 |
Pivot price | 12.17 | |||
Supports | First : | 12.27 | Second : | 11.63 |
MAs | MA(5) : | 12.27 | MA(20) : | 12.38 |
MA(100) : | 13.1 | MA(250) : | 13.02 | |
MACD | MACD : | -0.2 | Signal : | -0.2 |
%K %D | K(14,3) : | 69.4 | D(3) : | 50.8 |
RSI | RSI(14): 51.2 | |||
52-week | High : | 14.59 | Low : | 9.82 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ TWO ] has closed below upper band by 25.5%. Bollinger Bands are 17.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 12.61 - 12.67 | 12.67 - 12.71 |
Low: | 12.27 - 12.35 | 12.35 - 12.41 |
Close: | 12.35 - 12.48 | 12.48 - 12.56 |
Wed, 26 Sep 2018
K2M to Showcase First-of-its-Kind 3D-Printed Expandable Interbody System MOJAVE™ PL 3D at NASS 2018 - OrthoSpineNews
Thu, 30 Aug 2018
K2M Group Holdings, Inc. Announces Definitive Agreement To Be Acquired by Stryker Corporation - OrthoSpineNews
Thu, 30 Aug 2018
Leesburg spinal surgery company K2M Group to sell for $1.4B - Washington Business Journal - The Business Journals
Wed, 14 Mar 2018
K2M Launches Next-Generation YUKON™ OCT Spinal System at AANS/CNS 2018 - GlobeNewswire
Thu, 14 Jul 2016
Spine Publication Article Demonstrates K2M's MESA Rail™ Achieved "Significantly Better Curve Correction" in Treating ... - OrthoSpineNews
Wed, 16 Dec 2015
K2M Expands MIS Portfolio With Addition of Its EVEREST® Minimally Invasive XT Spinal System - OrthoSpineNews
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 103 (M) |
Shares Float | 103 (M) |
Held by Insiders | 0.6 (%) |
Held by Institutions | 66.3 (%) |
Shares Short | 3,170 (K) |
Shares Short P.Month | 2,410 (K) |
EPS | -1.61 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 15.4 |
Profit Margin | -41.4 % |
Operating Margin | 209.5 % |
Return on Assets (ttm) | -0.9 % |
Return on Equity (ttm) | -4.9 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 2.48 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 344 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -7.8 |
PEG Ratio | 3.4 |
Price to Book value | 0.8 |
Price to Sales | 5.01 |
Price to Cash Flow | 3.75 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |